The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.
A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia
Open accessAbstract
Objectives Few centers have adopted endovascular therapy for the treatment of acute mesenteric ischemia (AMI). We sought to evaluate the effect of endovascular therapy on outcomes for the treatment of AMI.Methods A single-center, retrospective cohort review was performed on all consecutive patients with thrombotic or embolic AMI presenting between 1999 and 2008. Patients with mesenteric venous thrombosis, nonocclusive mesenteric ischemia, and ischemia associated with aortic dissection were excluded. Demographic factors, preoperative metabolic status, and etiology were compared. Primary clinical outcomes included endovascular technical success, operative complications, and in-hospital mortality.Results Seventy consecutive patients were identified with AMI (mean age, 64 ± 13 years). Etiology of mesenteric ischemia was 65% thrombotic and 35% embolic occlusions. Endovascular revascularization was the preferred treatment (81%) vs operative therapy (19%). Successful endovascular treatment was achieved in 87%. Endovascular therapy required laparotomy in 69% vs traditional therapy in 100% (P < .05), with a median 52-cm necrotic bowel resected (interquartile range [IQR], 11-140 cm) vs 160 cm (IQR, 90-250 cm; P < .05), respectively. Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05). Successful endovascular treatment resulted in a mortality rate of 36% compared with 50% (P < .05) with traditional therapy, whereas the mortality rate for endovascular failures was 50%. Endovascular therapy was associated with improved mortality in thrombotic AMI (odds ratio, 0.10; 95% confidence interval, 0.10-0.76; P < .05).Conclusions Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach. Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 16 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“riod, the maximum lactate level and necrotic bowel requiring resection also negatively affected overall mortality.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This subgroup group did not experience any risk of death greater than those who underwent traditional therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Successful endovascular treatment was achieved in 87%.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“endovascular failures approached the mortality rate of traditional therapy (50% vs 50%).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the postoperative period, acute renal failure and pulmonary failure were significantly associated with death.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Duration of symptoms did not correlate with technical success (median, 36; IQR, 16-130 hours) compared with failures (median, 48; IQR, 24-84 hours; P ϭ .20).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The overall mortality was 39% for endovascular therapy vs 50% for traditional therapy (P ϭ .10).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular therapy required laparotomy in 69% vs traditional therapy in 100% (P < .05)”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An evaluation of factors associated with endovascular success found no differences in thrombotic (89%) vs embolic disease (85%; P ϭ .94)or in proximal occlusions (85%) vs distal occlusions (93%; P ϭ .79).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At the time of presentation, increasing age, history of coronary artery disease, peripheral arterial disease, and initial lactate Ͼ2.2 mmol/L were associated with increased risk of death.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 34
- Probably not a substantial claim. 27
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, the endovascular cohort was weighted with more thrombotic occlusions (72%) compared with the traditional cohort, which was weighted with more embolic occlusions (64%).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular failures resulted in a 50% mortality rate, similar to traditional therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular therapy was initiated in 56 patients (81%), representing the preferred treatment modality for acute mesenteric ischemia during this 9-year period.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedn = 56Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was a 9% initial endovascular failure rate in this series, with a total failure rate of 13%, resulting in an 87% technical success rate for endovascular therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although endovascular failures did not increase the mortality rate, endovascular successes reduced the mortality rate to 36% from 50%.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the current series, patients undergoing endovascular therapy presented with a median of 60 hours of abdominal pain, and duration of symptoms Ͻ24 hours was only weakly associated with death.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although not statistically significant, those with traditional therapy tended to have a slightly higher lactate concentration on admission (median, 3.5 mmol/L) compared with endovascular therapy (median, 2.3 mmol/L; P ϭ .06).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken into historical context, the endovascular group was weighted with thrombotic occlusions (72% of patients) yet resulted in the lowest subgroup mortality (33%).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“computed tomography angiography was used in essentially all patients to secure the diagnosis, and arteriography was primarily used with endovascular treatment.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The etiology was thrombotic occlusion in 65% compared with embolic occlusion in 35%.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedn = 70Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients treated with endovascular therapy were slightly older (65 Ϯ 12 vs 60 Ϯ 13 years; P Ͻ .05).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean age of the population was 64 Ϯ 13 years.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Strength:plain· not yet calibratedn = 70Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the resultant mortality rate was 36% for successful endovascular therapy compared with 50% for failures.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“of those requiring bowel resection, a median of 52 cm of bowel was resected compared with 160 cm for traditional therapy (P Ͻ .05).”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > RESULTS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The age difference, although statistically significant, is clinically negligible.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Initially, thrombotic arterial occlusions were first approached with endovascular therapy, followed by embolic occlusions as experience matured; therefore, a larger percentage of thrombotic occlusions were treated with endovascular therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The bleeding complications were relatively low: These patients did not experience hemorrhagic stroke, gastrointestinal bleeding was minor, and accessrelated bleeding was 9%.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular therapy afforded lower laparotomy rates, a significantly smaller bowel resection at the time of surgical exploration, and lower rates of renal and pulmonary failure.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although selection bias is evident in this retrospective analysis, there were few measurable differences in patients treated with endovascular therapy compared with traditional therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Endovascular failures were not associated with etiology or location of occlusion, but complete occlusions appeared to have a lower success rate than partial occlusions.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The 50% mortality of traditional therapy in our population is comparable to the mortality rate of 52% to 70% in recent reports, 1,5,11”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
What the sources say
- Not checked yetcites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
- Not checked yetcites [5] Kassahun, 2008, Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review, Langenbecks Arch Surg source
- Not checked yetcites [11] Cho, 2002, Long-term outcome after mesenteric artery reconstruction: a 37-year experience, J Vasc Surg source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When we examined the mortality for those patients, there is a trend for worse outcomes if they undergo infusion therapy longer.These subgroups are really too small to draw any conclusions; however, the mortality is 40% to 45%.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the embolectomy patients appear to have a higher mortality.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Our median time to laparotomy was 4 hours; therefore, most of these patients are revascularized with endovascular techniques at the time of their initial laparotomy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The only aspect that really made the two groups disparate was the etiology.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The majority of our patients received 1 day of therapy, and then there are about seven patients that received 2 or more days of infusion therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Strength:plain· not yet calibratedn = 7Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Most of these patients remain extubated.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Arthurs.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“56 patients underwent endovascular therapy altogether, 48%, or 28 patients, underwent lytic therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Strength:plain· not yet calibratedn = 56Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“they are also the ones that presented in the shortest amount of time and with the least amount of collateralization.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Acute mesenteric ischemia (AMI) accounts for only 0.1% of hospital admissions but is associated with a daunting mortality rate. 1”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
What the sources say
- Not checked yetcites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The number of vessels occluded, location of vessel occlusion, complete vs partial occlusion, and intraoperative adjuncts were based on the operating surgeon's dictation.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“these patients represent a cohort that was appropriately diagnosed with AMI”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
- The authors state this as an assumption: There are unidentified cases of acute mesenteric ischemia in which the vascular surgery service did not evaluate the patient.
None of the sources cited for this claim have been checked yet.
In the paper
“Endovascular therapy has been reported for the treatment of AMI in the form of case reports and case series; these initial results demonstrate feasibility, but the overall effect on outcomes is largely unknown.9,10”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
What the sources say
- Not checked yetcites [9] Yang, 2010, Successful recanalization of acute superior mesenteric artery thrombotic occlusion with primary aspiration thrombectomy, World J Gastroenterol source
- Not checked yetcites [10] Schoots, 2005, Thrombolytic therapy for acute superior mesenteric artery occlusion, J Vasc Interv Radiol source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Duration of abdominal pain did not discriminate patients who would benefit from endovascular therapy nor did it identify patients in whom endovascular therapy was prohibitive.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The determination of etiology (thrombotic or embolic) was based on the operative dictation of treatment.The classification of etiology was based on surgeon interpretation of the clinical presentation, the radiographic findings, and the operative findings; therefore, the etiology of occlusion should be interpreted in this context.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Given the small number of patients, we did not believe that multivariate modeling would be appropriate.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A randomized trial for this disease process would be challenging, given the relatively infrequent occurrence and acute presentation.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: Acute mesenteric ischemia is relatively infrequent, making it difficult for a single center to accumulate a large experience in a short period.
In the paper
“Thrombotic occlusions are typically associated with a higher mortality (70%) compared with embolic occlusions (54%), presumably due to the large volume of bowel subjected to ischemia. 1”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
What the sources say
- Not checked yetcites [1] Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A single-institutional procedural database was queried for all consecutive cases of AMI treated from December 1999 to December 2008.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
None of the sources cited for this claim have been checked yet.
In the paper
“Contemporary results report mortality ranges of 60% to 90%, 2 and the mortality rate has remained fairly constant during the past decade, with little improvement in results.[3][4][5]”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
What the sources say
- Not checked yetcites [2] Bradbury, 1995, Mesenteric ischaemia: a multidisciplinary approach, Br J Surg source
- Not checked yetcites [3][4][5]
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Multivariate analysis was not used secondary to the overall low number of observed cases within each group.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Avoiding urgent laparotomy may limit the secondary injury after the initial ischemic insult.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Initial endovascular revascularization may limit the initial ischemic insult and allow appropriate clinical resuscitation before surgical exploration.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This study was an institutional review board-approved study evaluating current therapy for AMI.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Computed tomography angiography affords the surgeon the opportunity to use endovascular therapy before laparotomy and also allows the clinician to assess the abdominal contents.14”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
What the sources say
- Not checked yetcites [14] Shih, 2007, CTA and MRA in mesenteric ischemia, AJR Am J Roentgenol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Surgeon selection bias cannot be avoided.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, endovascular revascularization could potentially restore bowel perfusion more rapidly than open visceral exposure, surgical embolectomy, or surgical bypass grafting.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with thrombotic or embolic etiologies for AMI were included.Patients presenting with AMI secondary to the following conditions were excluded: mesenteric venous thrombosis, nonocclusive mesenteric ischemia, aortic dissections complicated by visceral ischemia, and visceral ischemia occurring as part of an investigational device exemption protocol.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > METHODS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“I think that avoiding the insult of the laparotomy does give the opportunity to spare more bowel.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using endovascular therapy as the primary modality for AMI reduces the need for laparotomy, reduces length of bowel resection, and limits acute renal and pulmonary failure.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > CONCLUSIONS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“I think that endovascular therapy is just as good as open therapy.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > Dr Sean P. Roddy (Albany, NY
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endovascular therapy has altered the management of AMI, and there are measurable advantages to this approach.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > CONCLUSIONS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“this report affords details such as diagnostics, laboratory analysis, operative management, length of bowel resection, and postoperative complications that cannot be retrieved from large national databases.”
§ A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper relies on this without support.
The endovascular and traditional treatment groups are comparable enough that the observed differences in outcomes can be attributed to the treatment modality rather than to confounding by baseline characteristics.
“Multivariate analysis was not used secondary to the overall low number of observed cases within each group.”
“Using endovascular therapy as the primary modality for AMI reduces complications and improves outcomes.”
The paper relies on this without support.
Acute mesenteric ischemia is relatively infrequent, making it difficult for a single center to accumulate a large experience in a short period.
“given the relative infrequency of this disease, it is difficult for any one center to obtain a large experience over a relatively short interval.”
The authors state this as an assumption.
There are unidentified cases of acute mesenteric ischemia in which the vascular surgery service did not evaluate the patient.
“presumably, there are unidentified cases of AMI in which the vascular surgery service did not evaluate the patient.”
The paper relies on this without support.
The variability and error in determining exact etiology is uniform across articles reporting outcomes for acute mesenteric ischemia.
“However, the variability and error associated with determining the exact etiology is uniform across articles reporting outcomes for AMI.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown that endovascular therapy is associated with lower rates of mortality and bowel resection than the traditional, open approach [11–13].”
From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All studies have shown a benefit for endovascular therapy compared to open surgery in terms of lower bowel resection rates and lower 30-day mortality rates.”
From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [13]
Experimental — accuracy not yet measuredIn the citing paper
“a recent single-institution publication from the Cleveland Clinic by Arthurs et al 4 in which 56 of 70 patients with AMI underwent initial endovascular treatment.The group demonstrated a high success rate with only nine of 56 treatment failures and a lower in-hospital mortality rate with endovascular treatment of AMI compared to traditional open surgical treatment (36% vs 50%; P Ͻ .05).”
From Revascularization for acute mesenteric ischemia (2012) · cites this paper as [4]
In the citing paper
“Over the last decade, the use of endovascular therapy for treatment of patients with AMI has escalated dramatically at most institutions and has been associated with lower mortality than traditional open surgical therapy.4,5”
From Revascularization for acute mesenteric ischemia (2012) · cites this paper as [4]
In the citing paper
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
In the citing paper
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
In the citing paper
“Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included [8–11, 14, 25, 26].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
In the citing paper
“As with other authors in recent years, an increase in arteriosclerotic occlusions to the main etiology was also observed in our study (49%) [11, 17].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
In the citing paper
“In fact, only arteriosclerotic occlusions were treated by ET so that the endovascular failure can be explained by the heavily calcified visceral aortas and mesenteric vessel orifices [11, 23].”
From Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Renal-failure significance differs between abstract and table
MajorThe abstract reports P < .05 for the 27% versus 50% acute renal failure comparison, while Table III reports P = .14 for the same comparison.
“Acute renal failure and pulmonary failure occurred less frequently with endovascular therapy (27% vs 50%; P < .05 and 27% vs 64%; P < .05).”
“Acute renal failure, % 27 50 .14Pulmonary failure, % 27 64 Ͻ.05”
Overall mortality comparison has two P values
MinorThe Results text gives P = .10 for the 39% versus 50% mortality comparison, whereas Table III gives P = .15.
“The overall mortality was 39% for endovascular therapy vs 50% for traditional therapy (P ϭ .10).”
“Mortality, % 39 50 .15”
Confidence-interval lower bounds differ
MinorFor the thrombotic AMI mortality odds ratio of 0.10, the abstract gives a confidence-interval lower bound of 0.10, but the Results section gives 0.17. The latter interval also excludes the reported point estimate.
“Endovascular therapy was associated with improved mortality in thrombotic AMI (odds ratio, 0.10; 95% confidence interval, 0.10-0.76;P < .05).”
“endovascular therapy significantly reduced the mortality for thrombotic occlusions (mortality, 33%; odds ratio, 0.10; 95% confidence interval, 0.17-0.76;P Ͻ .05)”
Lytic-therapy count and percentage disagree
MinorThe discussion says 28 of 56 endovascular patients received lytic therapy. That is 50%, not the stated 48%.
Reported 48 · recomputed 50
“56 patients underwent endovascular therapy altogether, 48%, or 28 patients, underwent lytic therapy.”
Extended-infusion count conflicts with duration percentages
MinorThe Results section says 36% received two days of infusion and 5% received three days-about 11 of the approximately 27-28 lytic-therapy patients. The discussion instead says about seven received two or more days.
“Duration of thrombolysis infusion was most commonly 1 day (58%), with 36% of patients receiving 2 days, and 5% receiving 3 days of infusion.”
“The majority of our patients received 1 day of therapy, and then there are about seven patients that received 2 or more days of infusion therapy.”
Citations
Cites
Systematic review of survival after acute mesenteric ischaemia according to disease aetiology
Schoots, I. G., Koffeman, G. I., Legemate, D. A., Levi, M., & van Gulik, T. M. (2004) · Journal of British Surgery · doi:10.1002/bjs.4459 · Cited by 502
Chronic mesenteric ischemia: open surgery versus percutaneous angioplasty and stenting
Kasirajan, K., O'Hara, P. J., Gray, B. H., Hertzer, N. R., Clair, D. G., Greenberg, R. K., Krajewski, L. P., Beven, E. G., & Ouriel, K. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.111808 · Cited by 275
Self-citationUnchanged high mortality rates from acute occlusive intestinal ischemia: six year review
Kassahun, W. T., Schulz, T., Richter, O., & Hauss, J. (2008) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-007-0263-5 · Cited by 262
Mesenteric ischaemia: A multidisciplinary approach
Bradbury, A. W., Brittenden, J., McBride, K., & Ruckley, C. V. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800821105 · Cited by 239
The clinical course of asymptomatic mesenteric arterial stenosis
Thomas, J. H., Blake, K., Pierce, G. E., Hermreck, A. S., & Seigel, E. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70263-0 · Cited by 231
Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia
Wyers, M. C., Powell, R. J., Nolan, B. W., & Cronenwett, J. L. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.10.047 · Cited by 165
Acosta, S., Ögren, M., Sternby, N.-H., Bergqvist, D., & Björck, M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000154269.52294.57 · Cited by 162
Failure to improve outcome in acute mesenteric ischaemia: seven-year review
Mamode, I. P. (1999) · The European Journal of Surgery · doi:10.1080/110241599750007054 · Cited by 154
Thrombolytic therapy for acute superior mesenteric artery occlusion
Schoots, I. G., Levi, M. M., Reekers, J. A., Lameris, J. S., & van Gulik, T. M. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000141719.24321.0b · Cited by 152
Long-term outcome after mesenteric artery reconstruction: a 37-year experience
Cho, J.-S., Carr, J. A., Jacobsen, G., Shepard, A. D., Nypaver, T. J., & Reddy, D. J. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.118593 · Cited by 145
Flagged first, then by citations
1 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658
Halliday, A. W., & Bax, J. J. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.03.004 · Cited by 660
Clair, D. G., & Beach, J. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1503884 · Cited by 589
Self-citationAcute mesenteric ischemia: guidelines of the World Society of Emergency Surgery
Bala, M., Kashuk, J., Moore, E. E., Kluger, Y., Biffl, W., Gomes, C. A., Ben-Ishay, O., Rubinstein, C., Balogh, Z. J., Civil, I., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0150-5 · Cited by 574
“There are no randomized controlled trials comparing laparotomy versus endovascular treatment as a first line strategy for the management AMI [10, 58, 59].”
MethodAcute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery.
Bala, M., Catena, F., Kashuk, J., De Simone, B., Gomes, C. A., Weber, D., Sartelli, M., Coccolini, F., Kluger, Y., Abu-Zidan, F. M., et al. (2022) · World Journal of Emergency Surgery · doi:10.1186/s13017-022-00443-x · Cited by 380
Gastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Lalošević, M. S., Milosavljević, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 348
“Studies by Schermerhon and Arthus showed that endovascular therapy is associated with lower mortality when compared to open revascularization (16% vs 28%) [97, 98] and is preferable in elderly who usually have a plethora of other co-morbidities making them poor candidates for open surgery.”
BackgroundAboyans, V., Ricco, J., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T. U., Collet, J., Czerny, M., Carlo, M. D., Debus, S., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.07.018 · Cited by 1,027
The Diagnosis of Acute Mesenteric Ischemia: A Systematic Review and Meta-analysis
Cudnik, M. T., Darbha, S., Jones, J., Macedo, J., Stockton, S. W., & Hiestand, B. C. (2013) · Academic Emergency Medicine · doi:10.1111/acem.12254 · Cited by 275
Nuzzo, A., Maggiori, L., Ronot, M., Becq, A., Plessier, A., Gault, N., Joly, F., Castier, Y., Vilgrain, V., Paugam, C., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.38 · Cited by 233
Comparison of open and endovascular treatment of acute mesenteric ischemia
Beaulieu, R. J., Arnaoutakis, K. D., Abularrage, C. J., Efron, D. T., Schneider, E., & Black, J. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.084 · Cited by 222
“While TPN infusion may occur independent of bowel resection (ie, as a method for providing bowel rest), Arthurs et al showed a significant increase in the length of small bowel resected in patients undergoing open revascularization for AMI (160 cm vs 59 cm), which may increase the risks of requiring TPN.15 Endovascula…”
BackgroundMethodInfluentialACR appropriateness criteria® imaging of mesenteric ischemia
Oliva, I. B., Davarpanah, A. H., Rybicki, F. J., Desjardins, B., Flamm, S. D., Francois, C. J., Gerhard-Herman, M. D., Kalva, S. P., Ashraf Mansour, M., Mohler, E. R., et al. (2013) · Abdominal Imaging · doi:10.1007/s00261-012-9975-2 · Cited by 200
Revascularization for acute mesenteric ischemia
Ryer, E. J., Kalra, M., Oderich, G. S., Duncan, A. A., Gloviczki, P., Cha, S., & Bower, T. C. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.12.017 · Cited by 188
Modern treatment of acute mesenteric ischaemia
Acosta, S., & Björck, M. (2013) · British journal of surgery · doi:10.1002/bjs.9330 · Cited by 183
Ogino, H., Iida, O., Akutsu, K., Chiba, Y., Hayashi, H., Ishibashi‐Ueda, H., Kaji, S., Kato, M., Komori, K., Matsuda, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0794 · Cited by 182
Current status on plasma biomarkers for acute mesenteric ischemia
Acosta, S., & Nilsson, T. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0660-z · Cited by 157
Klar, E., Rahmanian, P. B., Bücker, A., Hauenstein, K., Jauch, K., & Luther, B. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0249 · Cited by 162
“Because of patients’ high comorbidity rate (average age above 68 years) and the major access trauma of open vascular reconstruction, and thanks to the advances in endovascular techniques, indirect catheter techniques using transfemoral or transaxillary access should be favored when possible (12).”
BackgroundCorcos, O., Castier, Y., Sibert, A., Gaujoux, S., Ronot, M., Joly, F., Paugam, C., Bretagnol, F., Abdel–Rehim, M., Francis, F., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.027 · Cited by 142
Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis
Tamme, K., Reintam Blaser, A., Laisaar, K.-T., Mändul, M., Kals, J., Forbes, A., Kiss, O., Acosta, S., Bjørck, M., & Starkopf, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062846 · Cited by 112
Gastro-Intestinal Vascular Emergencies
Corcos, O., & Nuzzo, A. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.08.006 · Cited by 104
Koelemay, M. J., Geelkerken, R. H., Kärkkäinen, J., Leone, N., Antoniou, G. A., de Bruin, J. L., Gombert, A., Gottsätter, A., Iborra, E., Ronchey, S., et al. (2025) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2025.06.010 · Cited by 123
Oderich, G. S., Macedo, R., Stone, D. H., Woo, E. Y., Panneton, J. M., Resch, T., Dias, N. V., Sonesson, B., Schermerhorn, M. L., Lee, J. T., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.086 · Cited by 97
ACR appropriateness criteria® imaging of mesenteric ischemia
Ginsburg, M., Obara, P., Lambert, D. L., Hanley, M., Steigner, M. L., Camacho, M. A., Chandra, A., Chang, K. J., Gage, K. L., Peterson, C. M., et al. (2018) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2018.09.018 · Cited by 99
Serological biomarkers for acute mesenteric ischemia
Memet, O., Zhang, L., & Shen, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.51 · Cited by 88
Trends in treatment and mortality for mesenteric ischemia in the United States from 2000 to 2012
Zettervall, S. L., Lo, R. C., Soden, P. A., Deery, S. E., Ultee, K. H., Pinto, D. S., Wyers, M. C., & Schermerhorn, M. L. (2017) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.01.007 · Cited by 88
Acute type B aortic dissection complicated by visceral ischemia
Jonker, F. H. W., Patel, H. J., Upchurch, G. R., Williams, D. M., Montgomery, D. G., Gleason, T. G., Braverman, A. C., Sechtem, U. P., Fattori, R., Eusanio, M. D., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.012 · Cited by 89
Roussel, A., Castier, Y., Nuzzo, A., Pellenc, Q., Sibert, A., Panis, Y., Bouhnik, Y., & Corcos, O. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.06.204 · Cited by 92
Bobadilla, J. L. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.04.002 · Cited by 93
Contemporary Management of Acute Mesenteric Ischemia in the Endovascular Era
Lim, S., Halandras, P. M., Bechara, C. F., Aulivola, B., & Crisostomo, P. R. (2018) · Vascular and Endovascular Surgery · doi:10.1177/1538574418805228 · Cited by 92
Retrograde open mesenteric stenting for acute mesenteric ischemia
Blauw, J. T. M., Meerwaldt, R., Brusse-Keizer, M. G. J., Kolkman, J. J., Gerrits, D. G., & Geelkerken, R. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.001 · Cited by 83
Endovascular Therapy as a Primary Revascularization Modality in Acute Mesenteric Ischemia
Kärkkäinen, J. M., Lehtimäki, T. T., Saari, P., Hartikainen, J., Rantanen, T., Paajanen, H., & Manninen, H. (2015) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1064-9 · Cited by 77
The importance of open emergency surgery in the treatment of acute mesenteric ischemia
Duran, M., Pohl, E., Grabitz, K., Schelzig, H., Sagban, T. A., & Simon, F. (2015) · World Journal of Emergency Surgery · doi:10.1186/s13017-015-0041-6 · Cited by 76
“However, another study reported lower morbidity and mortality using the endovascular method [20].”
ResultRaupach, J., Lojík, M., Chovanec, V., Renc, O., Strýček, M., Dvorak, P., Hoffmann, P., Guňka, I., Ferko, A., Ryška, P., et al. (2015) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1156-6 · Cited by 71
Early Endovascular Treatment of Superior Mesenteric Occlusion Secondary to Thromboemboli
Jia, Z., Jiang, G., Tian, F., Zhao, J., Li, S., Wang, K., Wang, Y., Jiang, L., & Wang, W. (2013) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2013.09.025 · Cited by 71
Management of Acute Mesenteric Ischemia: A Critical Review and Treatment Algorithm
Zhao, Y., Yin, H., Yao, C., Deng, J., Wang, M., Li, Z., & Chang, G. (2016) · Vascular and Endovascular Surgery · doi:10.1177/1538574416639151 · Cited by 64
A study on 107 patients with acute mesenteric ischemia over 30 years
Alhan, E., Usta, A., Çekiç, A., Saglam, K., Türkyılmaz, S., & Cinel, A. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.07.011 · Cited by 63
Surgical management of peritonitis secondary to acute superior mesenteric artery occlusion
Acosta, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9936 · Cited by 64
“…al [22] 2009 United States 2000-2006 1857 (35) 2138 (41) 1615 (31) Block et al [18] 2010 Sweden 1999-2006 42 (26) 80 (51) 1 61 (37) Arthurs et al [23] 2011 Cleveland, OH, United States 1999-2008 56 (80) 60 (80) 29 (41) Ryer et al [24] 2012 Rochester, MI, United States 1990-2010 11 (12) 38 (41)…”
BackgroundThrombolysis for acute occlusion of the superior mesenteric artery
Björnsson, S., Björck, M., Block, T., Resch, T., & Acosta, S. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.054 · Cited by 63
“Several clinical tudies have also found an association between high plasma actate values and death.(3,21,22) Plasma D-dimer, however, as elevated in all measured cases, which confirms previous ndings that D-dimer is a highly sensitive test for acute ntestinal ischemia(6,23) but lacks specificity.”
BackgroundMethodResultInfluentialPlasma biomarkers for early diagnosis of acute intestinal ischemia
Powell, A., & Armstrong, P. (2014) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2015.01.008 · Cited by 60
Yang, S., Fan, X., Ding, W., Liu, B., Meng, J., Xu, D., He, C., Yu, W., Wu, X., & Li, J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.018 · Cited by 58
“It has shown measurable advantages to traditional open treatment for AMI, and become the central part of the multidisciplinary stepwise management strategy [29–31].”
Knowles, M., Nation, D. A., Timaran, D. E., Gomez, L. F., Baig, M. S., Valentine, R. J., & Timaran, C. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.06.113 · Cited by 60
Carver, T. W., Vora, R. S., & Taneja, A. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2015.11.001 · Cited by 58
Sgroi, M. D., Kabutey, N.-K., Krishnam, M. S., et al. (2014) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.05.020 · Cited by 56
Evolution in the Presentation, Treatment, and Outcomes of Patients with Acute Mesenteric Ischemia
Chou, E. L., Wang, L. J., McLellan, R. M., Feldman, Z. M., Latz, C. A., LaMuraglia, G. M., Clouse, W. D., Eagleton, M. J., & Conrad, M. F. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.01.116 · Cited by 51
Self-citationEslami, M. H., Rybin, D. V., Doros, G. D., McPhee, J. T., & Farber, A. M. (2015) · Vascular · doi:10.1177/1708538115577730 · Cited by 54
“In the work presented here the overall mortality rates were significantly better than previously reported rates of 50–80%.(2,3,14,16) But our work suggests that even though majority of these procedures were performed using endovascular procedures, the mortality rates have remained unchanged in the last decade.”
BackgroundResultTolonen, M., Lemma, A., Vikatmaa, P., Peltola, E., Mentula, P., Björkman, P., Leppäniemi, A., & Sallinen, V. (2021) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000003305 · Cited by 46
Outcomes of antegrade and retrograde open mesenteric bypass for acute mesenteric ischemia
Scali, S. T., Ayo, D., Giles, K. A., Gray, S. E., Kubilis, P. S., Back, M. R., Fatima, J., Arnaoutakis, D. J., Berceli, S. A., Beck, A. W., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.04.063 · Cited by 52
Salsano, G., Salsano, A., Sportelli, E., Petrocelli, F., Dahmane, M., Spinella, G., Pane, B., Mambrini, S., Palombo, D., & Santini, F. (2018) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-017-1749-3 · Cited by 52
“It should also be underscored that in case of endovascular failure with suboptimal revascularization, surgical approach is not yet precluded and a second-look operation does not appear to increase in-hospital mortality [10].”
InfluentialUrine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients
Salim, S. Y., Young, P. Y., Churchill, T. A., & Khadaroo, R. G. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2016.07.017 · Cited by 48
Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience
Freitas, B., Bausback, Y., Schuster, J., Ülrich, M., Bräunlich, S., Schmidt, A., & Scheinert, D. (2018) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.11.041 · Cited by 49
Acute mesenteric ischemia (Part II) – Vascular and endovascular surgical approaches
Kärkkäinen, J. M., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.11.003 · Cited by 48
Systematic review and meta-analysis of endovascular treatment for acute mesenteric ischaemia
El Farargy, M., Abdel Hadi, A., Abou Eisha, M., Bashaeb, K., & Antoniou, G. A. (2017) · Vascular · doi:10.1177/1708538116689353 · Cited by 43
“An increased co-morbid burden, poor collateral circulation and a delayed diagnosis are some of the suggested predictors of poor outcomes.(4,5,9,18) Recanalisation has been recommended even in those patients with delayed presentation, especially those with thrombotic mesenteric disease.”
BackgroundEndovascular therapy for acute mesenteric ischemia: an NSQIP analysis
Branco, B. C., Montero-Baker, M. F., Aziz, H., Taylor, Z., & Mills, J. L. (2015) · The American Surgeon™ · doi:10.1177/000313481508101131 · Cited by 43
Erben, Y., Protack, C. D., Jean, R. A., Sumpio, B. J., Miller, S. M., Liu, S., Trejo, G., & Sumpio, B. E. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.078 · Cited by 40
“However, in recent years, endovascular treatment has gained popularity in the management of this lethal disease.(4,5) This trend in endovascular therapy has been observed in several large database analyses and metaanalyses; despite the continued predilection for open revascularization (OPEN), endovascular techniques (…”
BackgroundZhang, Z., Wang, D., Li, G., Wang, X., Wang, Y., Li, G., & Jiang, T. (2017) · BioMed Research International · doi:10.1155/2017/1964765 · Cited by 39
Najdawi, M., Garzelli, L., Nuzzo, A., Huguet, A., Raynaud, L., Paulatto, L., Panis, Y., Ben Abdallah, I., Castier, Y., Sibert, A., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08660-3 · Cited by 38
“The rate of intestinal resection varies in the literature, from 14.4% of patients who underwent endovascular procedures in the series by Beaulieu et al [2] to 69% in that by Arthurs et al [3].”
BackgroundMethodInfluentialACR Appropriateness Criteria ® Radiologic Management of Mesenteric Ischemia
Fidelman, N. A., AbuRahma, A. F., Cash, B. D., Kapoor, B. S., Knuttinen, M. G., Minocha, J., Rochon, P. J., Shaw, C. M., Ray, C. E., & Lorenz, J. M. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.02.014 · Cited by 37
The role of endovascular therapy in acute mesenteric ischemia
Ierardi, A. M. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0164 · Cited by 37
“Arthurs 2011 [8] 56 35% 65% 0% Abdominal pain 92%, Nausea 69%, Emesis 51%, Bloody diarrhea 31% SMA 66% SMA+ celiac artery 34% 48% 11% 32%”
BackgroundInfluentialResults of retrograde open mesenteric stenting for acute thrombotic mesenteric ischemia
Roussel, A., Schiava, N. D., Coscas, R., Pellenc, Q., Boudjelit, T., Goëau-Brissonnière, O., Corcos, O., Lermusiaux, P., Coggia, M., & Castier, Y. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.07.058 · Cited by 38
Mesenteric vascular treatment 2016: from open surgical repair to endovascular revascularization
Blauw, J. T. M., Bulut, T., Oderich, G. S., & Geelkerken, B. R. H. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.01.002 · Cited by 36
Björck, M., Orr, N., & Endean, E. D. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.04.431 · Cited by 35
High risk and low prevalence diseases: Mesenteric ischemia
Molyneux, K., Beck‐Esmay, J., Koyfman, A., & Long, B. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.01.001 · Cited by 35
Percutaneous mechanical thrombectomy of superior mesenteric artery embolism
Kuhelj, D., Kavčič, P., & Popovič, P. (2013) · Radiology and Oncology · doi:10.2478/raon-2013-0029 · Cited by 32
Ding, W., Wang, K., Liu, B., Fan, X., Wang, S., Cao, J., Wu, X., & Li, J. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000799 · Cited by 31
Mendes, B. C., Oderich, G. S., Tallarita, T., Kanamori, K. S., Kalra, M., DeMartino, R. R., Shuja, F., & Johnstone, J. K. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.12.076 · Cited by 32
Arterial thrombosis in unusual sites: A practical review
O’Donnell, M., Shatzel, J. J., Olson, S. R., Daughety, M. M., Nguyen, K. P., Hum, J., & DeLoughery, T. G. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13165 · Cited by 28
Mesenteric ischemia: a radiologic perspective
Sinha, D., Kale, S. K., Kundaragi, N. G., & Sharma, S. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02867-y · Cited by 26
Atre, I. D., Eurboonyanun, K., O’Shea, A., Lahoud, R. M., Shih, A. R., Kalva, S. P., Harisinghani, M. G., & Hedgire, S. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02558-8 · Cited by 28
“demonstrated that the use of EVT as the primary modality for AMI reduces complications with improved outcomes [25].”
Acute mesenteric ischemia in elderly patients
Kärkkäinen, J. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1212657 · Cited by 28
Yang, S., Zhang, L., Liu, K., Fan, X., Ding, W., He, C., Wu, X., & Li, J. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2016.02.019 · Cited by 27
Open and endovascular management of acute mesenteric ischaemia: a systematic review
Murphy, B., Dejong, C. H. C., & Winter, D. C. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05149-x · Cited by 27
“Supporting this, Arthurs et al. [9] found that patients who underwent open surgery trended towards a higher serum lactate measurement than the endovascular group.”
BackgroundResultInfluentialRabuffi, P., Vagnarelli, S., Bruni, A. D. C., et al. (2019) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-019-02354-y · Cited by 27
Arya, S., Kingman, S., Knepper, J. P., Eliason, J. L., Henke, P. K., & Rectenwald, J. E. (2015) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.07.038 · Cited by 26
Lendzion, R. J., Frahm‐Jensen, G., & Keck, J. O. (2022) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0042-1743283 · Cited by 30
Аlexander, K., Ismail, M., Alexander, M., Ivan, T., Olga, V., Dmitry, S., Головина, А. А., & Андреевич, М. Д. (2019) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2019.07.077 · Cited by 25
Is open surgery or endovascular therapy best to treat acute mesenteric occlusive disease?
Smith, S. F., Gollop, N. D., Klimach, S. G., & Murray, P. J. (2013) · International Journal of Surgery · doi:10.1016/j.ijsu.2013.10.003 · Cited by 21
A Shifting Trend Towards Endovascular Intervention in the Treatment of Acute Mesenteric Ischemia
Naazar, A. A., Omair, A., Chu, S. H., Keane, K. G., & Weber, D. G. (2021) · Cureus · doi:10.7759/cureus.18544 · Cited by 24
Li, W., Cao, S., Zhang, Z., Zhu, R., Chen, X., Liu, B., & Feng, H. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.833464 · Cited by 25
“Other studies (11, 15) reported that increasing age, history of peripheral arterial disease, coronary artery disease, initial lactate >2.”
BackgroundInfluentialGarzelli, L., Nuzzo, A., Hamon, A., Abdallah, I. B., Grégory, J., Raynaud, L., Paulatto, L., Burgio, M. D., Castier, Y., Panis, Y. H., et al. (2022) · Insights into Imaging · doi:10.1186/s13244-022-01339-9 · Cited by 22
Swerdlow, N. J., Varkevisser, R. R. B., Soden, P. A., Zettervall, S. L., McCallum, J. C., Li, C., Wyers, M. C., & Schermerhorn, M. L. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.05.024 · Cited by 22
Mesenteric ischemia in acute aortic dissection
Orihashi, K. (2018) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-018-0970-6 · Cited by 21
Orr, N. T., & Endean, E. D. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.04.026 · Cited by 18
Shi, Y., Zhao, B., Zhou, Y., Chen, L., Su, H., & Gu, J. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.07.084 · Cited by 21
Engineered Vasculature for Cancer Research and Regenerative Medicine
Nguyen, H. T., Peirsman, A., Tirpáková, Z., Mandal, K., Vanlauwe, F., Maity, S., Kawakita, S., Khorsandi, D., Herculano, R. D., Umemura, C., et al. (2023) · Micromachines · doi:10.3390/mi14050978 · Cited by 19
Tual, A., Garzelli, L., Nuzzo, A., Corcos, O., Castier, Y., Abdallah, I. B., & Ronot, M. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.01.041 · Cited by 19
Zhuang, X., Chen, F., Zhou, Q., Zhu, Y., & Yang, X. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01746-0 · Cited by 15
Mesenteric ischemia in acute aortic dissection
Orihashi, K. (2015) · Surgery Today · doi:10.1007/s00595-015-1193-4 · Cited by 20
“Favorable results after endovascular treatment have been reported [33, 34], and retrospective analysis has shown results equal to or better than those of conventional surgical treatment [35].”
ResultAcute mesenteric ischemia of arterial origin: Importance of early revascularization
Plumereau, F., Mucci, S., Naoures, P. L., Finel, J.-B., & Hamy, A. (2015) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.11.001 · Cited by 21
Yang, S., Wu, X., & Li, J. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.03.015 · Cited by 20
Local thrombolytic therapy in acute mesenteric ischemia
Yanar, F., Agcaoglu, O., Sarici, I. S., Sivrikoz, E., Ucar, A., Yanar, H., Aksoy, M., & Kurtoglu, M. (2013) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-8-8 · Cited by 19
“Thrombolytic therapy is an effective and quick treatment modality for AMI and may obviate surgery and has the potential to resolve the clot completely [15,16].”
Pengermä, P., Venesmaa, S., Karjalainen, J., Ukkonen, M., Saari, P., & Kärkkäinen, J. M. (2023) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2023.08.100 · Cited by 19
Zhang, Z., Chen, X., Li, C., Feng, H., Yu, H., & Zhu, R. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.08.096 · Cited by 20
Acute mesenteric ischaemia: imaging and intervention
Hawthorn, B. R., & Ratnam, L. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.06.001 · Cited by 18
Chirurgie des artères digestives
Marzelle, J., Brunetti, F., Cochennec, F., & Becquemin, J.-P. (2013) · EMC - Techniques chirurgicales - Chirurgie vasculaire · doi:10.1016/s0246-0459(12)60874-0 · Cited by 17
Midterm Clinical Outcomes of Retrograde Open Mesenteric Stenting for Mesenteric Ischemia
Cirillo-Penn, N. C., DeMartino, R. R., Rasmussen, T. E., Shuja, F., Colglazier, J. J., Kalra, M., Oderich, G. S., & Mendes, B. C. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.09.062 · Cited by 17
Garzelli, L., Dufay, R., Tual, A., Corcos, O., Cazals-Hatem, D., Vilgrain, V., Nuzzo, A., Ben Abdallah, I., & Ronot, M. (2024) · Radiology · doi:10.1148/radiol.230830 · Cited by 17
Antibiotic use in acute mesenteric ischemia: A review of the evidence and call to action
Tian, Y., Dhara, S., Barrett, C. D., Richman, A. P., & Brahmbhatt, T. S. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00486-3 · Cited by 17
“A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia [13] 2011 1999–2008 Retrospective Single Institution 70 Not mentioned.”
BackgroundMethodAcute and Chronic Ischemic Disorders of the Small Bowel
Prakash, V., Marin, M. L., & Faries, P. L. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0694-5 · Cited by 17
The Use of AngioVac for Symptomatic Aortic Thrombus Complicated by Mesenteric Ischemia
Monastiriotis, S., Gonzales, C. F., Kokkosis, A. A., et al. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.09.026 · Cited by 17
Zientara, A., Domenghino, A.-R., Schwegler, I., Bruijnen, H., Schnider, A., Weber, M., Gutknecht, S., & Attigah, N. (2021) · BMC Surgery · doi:10.1186/s12893-021-01102-9 · Cited by 18
Metadata
- Authors
- Arthurs, Z. M., Titus, J., Bannazadeh, M., Eagleton, M. J., Srivastava, S., Sarac, T. P., & Clair, D. G.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Arthurs, Zachary M.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 53
- Issue
- 3
- Pages
- 698-705
- ISSN
- 0741-5214 (ISSN-L)
- OpenAlex
- W2146977838
- Cited by
- 285
- References
- 15
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 13 · 2023: 23 · 2022: 14 · 2021: 16 · 2020: 19 · 2019: 25 · 2018: 19 · 2017: 29 · 2016: 18 · 2015: 26 · 2014: 21 · 2013: 19 · 2012: 10
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Vascular Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
- Health Sciences › Medicine › Surgery › Intestinal and Peritoneal Adhesions
- Keywords
- acute mesenteric ischemia, endovascular revascularization, mesenteric artery occlusion, bowel resection, in-hospital mortality, acute kidney injury, respiratory failure, surgical treatment
- MeSH terms
- Aged, Angioplasty, Balloon, Embolism, Female, Humans, Ischemia, Male, Mesenteric Vascular Occlusion, Middle Aged, Ohio, Respiratory Insufficiency, Retrospective Studies, Risk Factors, Thrombosis, Time Factors, Vascular Diseases, Vascular Surgical Procedures, Thrombolytic Therapy, Chi-Square Distribution, Odds Ratio, Treatment Outcome, Hospital Mortality, Embolectomy, Thrombectomy, Risk Assessment, Endovascular Procedures, Vascular Grafting, Acute Kidney Injury, Mesenteric Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
